De Novo Pharmaceuticals Limited

Calculating rank

USPTO Granted Patents = 2

% Expired Patents = 100.0

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Barry Porter (2 out of 2 patents)

Paul Gane (2 out of 2 patents)

Kenneth Keavey (2 out of 2 patents)

4. Raymond Paul Beckett (2 out of 38 patents)

5. Jac Wijkmans (1 out of 1 patent)

6. Lydia Saroglou (1 out of 1 patent)

7. Henriette Willems (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 7323596 - Antimicrobial agents (2008-01-29),

2. 7241921 - Bacterial enzyme inhibitors (2007-07-10),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#678 in

#6,535 in United Kingdom

GB

De Novo Pharmaceuticals Limited

Forward Citations = 0

7 inventors:

Barry Porter (2 out of 2 patents)

Paul Gane (2 out of 2 patents)

Kenneth Keavey (2 out of 2 patents)

4. Raymond Paul Beckett (2 out of 38 patents)

5. Jac Wijkmans (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: De Novo Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/de-novo-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]